Financial pressure on the NHS has never been greater, with £20bn in savings having to be found over the next four years.
In order to understand the opportunity that rebates offer to the prescribing budget and to develop a meaningful consensus view that can be shared across fellow professionals, consensus statements have been developed by a multidisciplinary group of professionals working in medicines optimisation and NHS procurement.
They are intended to be a starting point for the definition of a national consensus project for primary care rebate schemes across the UK.
Completing the HSJ questionnaire will allow you an opportunity to participate in the discussion and contribute to the consensus view.
What is a primary care rebate scheme?
- Primary care rebate schemes (PCRS) are contractual arrangements offered by pharmaceutical companies, or third-party companies, which offer financial rebates on GP prescribing expenditure for particular branded medicine(s).
- Any rebate given (or offered) is subsequent to the raising of an invoice, or invoices, to which it relates.
There are three type of primary care rebate scheme on offer:
- Standard discount (X%) based on sales of product from EPACT data;
- Discount paid on increased sales above historic level; and
- Discount paid on a banded system i.e. there are volume sales/market share thresholds for increasing levels of discount.
Please review each statement and indicate your level of agreement with it. While we will not use your name or position, it will be useful to us in the final analysis of all responses to these statements.
No comments yet